COVID-19 monoclonal antibody therapy can reduce hospitalizations, healthcare system stress

(University of South Florida (USF Health)) Monoclonal antibodies work well in reducing COVID-19 related emergency department visits and hospitalizations when administered early to high-risk patients, a study by the University of South Florida Health (USF Health) and Tampa General Hospital demonstrates. If used under FDA guidelines, the researchers suggest, this treatment can ease the pandemic's continuing burden on patients and on limited health care resources.